Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03189914
Title RX-3117 in Combination With Abraxane in Subjects With Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Indications

pancreatic cancer

Therapies

RX-3117

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.